GlassScriptPhysician profile
Omar J On
NPI 1295889871
$63,449.35
in general payments reported to CMS, 2019-2025
32 companies · $2,295 in 2025
The $2,295 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,669 · 2022: $20K · 2023: $18K · 2024: $17K · 2025: $2,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $11K · Travel and Lodging: $6,572 · Consulting Fee: $2,202 · Education: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,825.00 |
| Food and Beverage | $10,541.33 |
| Travel and Lodging | $6,572.11 |
| Consulting Fee | $2,202.00 |
| Education | $606.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $31,018.40 | 2021-2024 | Opzelura |
| Sun Pharmaceutical Industries INC. | $13,082.23 | 2021-2025 | Absorica Ld, Winlevi, Ilumya |
| Abbvie INC. | $7,674.84 | 2021-2025 | |
| Janssen Biotech, INC. | $1,691.28 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Amgen INC. | $1,232.14 | 2021-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $1,103.48 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $925.51 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $872.97 | 2021-2025 | |
| Pfizer INC. | $747.65 | 2021-2025 | |
| Verrica Pharmaceuticals INC. | $650.00 | 2024 | Ycanth |
| Ucb, INC. | $639.52 | 2021-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $622.17 | 2021-2025 | Jublia, Siliq, Duobrii |
| Regeneron Healthcare Solutions, INC. | $596.96 | 2021-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $452.59 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $361.88 | 2023-2025 | Zoryve |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $338.36 | 2021-2025 | Anzupgo, Adbry |
| Organon LLC | $276.01 | 2024-2025 | Vtama, Hadlima, Nexplanon |
| Galderma Laboratories, L.P. | $249.50 | 2021-2024 | Aklief, Twyneo |
| Novartis Pharmaceuticals Corporation | $149.09 | 2022-2025 | |
| Epi Health, LLC | $141.20 | 2021-2022 | |
| Almirall LLC | $113.37 | 2021 | |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Vyne Pharmaceuticals INC. | $61.32 | 2021 | |
| Botanix Sb INC | $61.06 | 2025 | Sofdra |
| Biofrontera INC. | $58.10 | 2023-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Paratek Pharmaceuticals, INC. | $56.43 | 2024 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.67 | 2023-2024 | Cyltezo |
| Mayne Pharma Commercial LLC | $51.10 | 2021 | |
| Organogenesis INC. | $20.60 | 2024 | Puraply Am |
| Dermira, INC. | $18.05 | 2021 | |
| Genentech USA, INC. | $16.48 | 2024 | Erivedge |
| Strata Skin Sciences, INC. | $15.39 | 2023 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar On listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.